elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Tamoxifen
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Tamoxifen
RIS
0.001
(Research Intensity Score)
Papers
164
Top papers
Tumor-Generated Reactive Oxygen Species Storm for High-Performance Ferroptosis Therapy
2023 · 220 citations
Cisplatin in Liver Cancer Therapy
2023 · 93 citations
Mitochondria Targeting of Oxidative Phosphorylation Inhibitors to Alleviate Hypoxia and Enhance Anticancer Treatment Efficacy
2025 · 35 citations
Biogenic copper oxide nanoparticles from Bacillus coagulans induced reactive oxygen species generation and apoptotic and anti-metastatic activities in breast cancer cells
2023 · 67 citations
Eco-Friendly Green Synthesis and Characterization of Silver Nanoparticles by Scutellaria multicaulis Leaf Extract and Its Biological Activities
2023 · 50 citations
Newest papers
Adipocyte-derived estrogen signaling influences TROP2 expression in ERα-positive breast cancer
2026
Environmental risk assessment of antineoplastic drugs: A case study in Florianópolis, Southern Brazil
2026
Phenotypic divergence in rotator cuff tear and volumetric muscle loss mouse models following fibroadipogenic progenitor depletion
2026
DFT and molecular docking investigation of tamoxifen interactions with metal-encapsulated boron nitride nanocages
2026
The POLR3A/ARG2/spermine axis drives tamoxifen resistance in breast cancer
2026
A sample from the 100 top papers behind Tamoxifen.
Create a free account to browse them all →
Tamoxifen's history
Research intensity over time
Explore Tamoxifen's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Tamoxifen's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link